Xtandi Uniunea Europeană - română - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostate neoplasme - terapia endocrină - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Invirase Uniunea Europeană - română - EMA (European Medicines Agency)

invirase

roche registration gmbh - saquinavir - infecții cu hiv - antivirale pentru uz sistemic - invirase este indicat pentru tratamentul pacienților adulți infectați cu hiv-1. invirase trebuie administrat numai în asociere cu ritonavir și alte medicamente antiretrovirale.